Skip to main content

Table 2 Maternal poliovirus type-specific antibody levels of the study participants

From: The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines

Group N Type Positive participants Positive rate (%) GMT Participants with different titers (1:)
< 8 8 ~ < 32 ≥32
1 109 I 82 75.23 17.57 27 47 35
II 49 44.95 8.39 60 33 16
III 29 26.61 6.13 80 20 9
2 125 I 98 78.40 18.44 27 50 48
II 43 34.40 6.73 82 30 13
III 23 18.40 5.33 102 19 4
3 127 I 90 70.87 17.99 37 39 51
II 46 36.22 6.69 81 35 11
III 21 16.54 5.59 106 14 7
4 124 I 96 77.42 21.21 28 40 56
II 47 37.90 6.44 77 42 5
III 33 26.61 6.41 91 23 10
5 124 I 95 76.61 19.15 29 45 50
II 46 37.10 6.92 78 36 10
III 31 25.00 5.79 93 25 6
  1. Group 1: low-dose Sabin IPV group. Group 2: medium-dose Sabin IPV group. Group 3: high-dose Sabin IPV group. Group 4: control Sabin IPV group. Group 5: control Salk IPV group